Public and Private Sector Approaches to Improving Pharmaceutical Quality in Bangladesh
Low-cost high-quality drugs benefit society and improve pharmaceutical company's competitive edge. This study presents the issues that must be considered to achieve these common objectives in Bangladesh. This is not a policy paper outlining ex...
| Main Authors: | , , |
|---|---|
| Format: | Working Paper |
| Language: | English English |
| Published: |
World Bank, Washington, DC
2021
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/892611467998809882/Public-and-private-sector-approaches-to-improving-pharmaceutical-quality-in-Bangladesh http://hdl.handle.net/10986/36110 |
| id |
okr-10986-36110 |
|---|---|
| recordtype |
oai_dc |
| spelling |
okr-10986-361102021-08-12T05:10:33Z Public and Private Sector Approaches to Improving Pharmaceutical Quality in Bangladesh Bumpas, Janet Kostermans, Kees Nair, Dinesh ACQUIRED IMMUNE DEFICIENCY SYNDROME INTELLECTUAL PROPERTY PROTECTION ACCESS TO DRUGS SALE OF STOCK PUBLIC HEALTH CARE INTERNATIONAL LEGAL DISPUTE INNOVATIVE NEW DRUGS TERTIARY SCHOOL ENROLLMENT TRADE AGREEMENTS TRADE-RELATED INTELLECTUAL PROPERTY Low-cost high-quality drugs benefit society and improve pharmaceutical company's competitive edge. This study presents the issues that must be considered to achieve these common objectives in Bangladesh. This is not a policy paper outlining exact recommendations; rather it is a discussion paper which explores the field and points towards options for Government and the local industry. Previous efforts to improve the drug quality in Bangladesh focused without much success on stricter regulation of the public market. This paper addresses this issue from a more private sector approach. The existing quality and price of pharmaceuticals are analyzed and alternative mechanisms are explored to improve the quality and cost competitiveness of Bangladesh's pharmaceuticals domestically and internationally. This paper also examines two external forces currently impacting Bangladesh's pharmaceutical sector which can provide opportunities for change. The first is World Trade Organization's (WTO)'s Trade Related Aspects of Intellectual Property (TRIPS), which grants Bangladesh domestic manufacturing opportunities and limited export advantages. Pursuing TRIPS opportunities must be carefully considered for the following reasons: they are time sensitive, require up-front investments, are likely influenced by international political pressures, provide unclear benefits, and China and India, the world leaders in low-cost pharmaceutical manufacturing, and are still extremely competitive. This paper concludes with policy and institutional suggestions for Government to improve the price and quality competitiveness of Bangladesh's pharmaceuticals. The recommendations are targeted at improving the domestic market, increasing export potential and taking advantage of TRIPS. The conclusions are preliminary and more analysis is suggested. 2021-08-11T20:14:43Z 2021-08-11T20:14:43Z 2007-08 Working Paper http://documents.worldbank.org/curated/en/892611467998809882/Public-and-private-sector-approaches-to-improving-pharmaceutical-quality-in-Bangladesh http://hdl.handle.net/10986/36110 English en CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo World Bank World Bank, Washington, DC Publications & Research Publications & Research :: Working Paper South Asia Bangladesh |
| repository_type |
Digital Repository |
| institution_category |
Foreign Institution |
| institution |
Digital Repositories |
| building |
World Bank Open Knowledge Repository |
| collection |
World Bank |
| language |
English English |
| topic |
ACQUIRED IMMUNE DEFICIENCY SYNDROME INTELLECTUAL PROPERTY PROTECTION ACCESS TO DRUGS SALE OF STOCK PUBLIC HEALTH CARE INTERNATIONAL LEGAL DISPUTE INNOVATIVE NEW DRUGS TERTIARY SCHOOL ENROLLMENT TRADE AGREEMENTS TRADE-RELATED INTELLECTUAL PROPERTY |
| spellingShingle |
ACQUIRED IMMUNE DEFICIENCY SYNDROME INTELLECTUAL PROPERTY PROTECTION ACCESS TO DRUGS SALE OF STOCK PUBLIC HEALTH CARE INTERNATIONAL LEGAL DISPUTE INNOVATIVE NEW DRUGS TERTIARY SCHOOL ENROLLMENT TRADE AGREEMENTS TRADE-RELATED INTELLECTUAL PROPERTY Bumpas, Janet Kostermans, Kees Nair, Dinesh Public and Private Sector Approaches to Improving Pharmaceutical Quality in Bangladesh |
| geographic_facet |
South Asia Bangladesh |
| description |
Low-cost high-quality drugs benefit
society and improve pharmaceutical company's
competitive edge. This study presents the issues that must
be considered to achieve these common objectives in
Bangladesh. This is not a policy paper outlining exact
recommendations; rather it is a discussion paper which
explores the field and points towards options for Government
and the local industry. Previous efforts to improve the drug
quality in Bangladesh focused without much success on
stricter regulation of the public market. This paper
addresses this issue from a more private sector approach.
The existing quality and price of pharmaceuticals are
analyzed and alternative mechanisms are explored to improve
the quality and cost competitiveness of Bangladesh's
pharmaceuticals domestically and internationally. This paper
also examines two external forces currently impacting
Bangladesh's pharmaceutical sector which can provide
opportunities for change. The first is World Trade
Organization's (WTO)'s Trade Related Aspects of
Intellectual Property (TRIPS), which grants Bangladesh
domestic manufacturing opportunities and limited export
advantages. Pursuing TRIPS opportunities must be carefully
considered for the following reasons: they are time
sensitive, require up-front investments, are likely
influenced by international political pressures, provide
unclear benefits, and China and India, the world leaders in
low-cost pharmaceutical manufacturing, and are still
extremely competitive. This paper concludes with policy and
institutional suggestions for Government to improve the
price and quality competitiveness of Bangladesh's
pharmaceuticals. The recommendations are targeted at
improving the domestic market, increasing export potential
and taking advantage of TRIPS. The conclusions are
preliminary and more analysis is suggested. |
| format |
Working Paper |
| author |
Bumpas, Janet Kostermans, Kees Nair, Dinesh |
| author_facet |
Bumpas, Janet Kostermans, Kees Nair, Dinesh |
| author_sort |
Bumpas, Janet |
| title |
Public and Private Sector Approaches to Improving Pharmaceutical Quality in Bangladesh |
| title_short |
Public and Private Sector Approaches to Improving Pharmaceutical Quality in Bangladesh |
| title_full |
Public and Private Sector Approaches to Improving Pharmaceutical Quality in Bangladesh |
| title_fullStr |
Public and Private Sector Approaches to Improving Pharmaceutical Quality in Bangladesh |
| title_full_unstemmed |
Public and Private Sector Approaches to Improving Pharmaceutical Quality in Bangladesh |
| title_sort |
public and private sector approaches to improving pharmaceutical quality in bangladesh |
| publisher |
World Bank, Washington, DC |
| publishDate |
2021 |
| url |
http://documents.worldbank.org/curated/en/892611467998809882/Public-and-private-sector-approaches-to-improving-pharmaceutical-quality-in-Bangladesh http://hdl.handle.net/10986/36110 |
| _version_ |
1764484448779239424 |